Mahendrabhai Gulabdas Patel has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mahendrabhai Gulabdas Patel, a promoter/substantial shareholder of Lincoln Pharmaceuticals, has submitted a disclosure under Regulation 31(4) of SEBI's Substantial Acquisition of Shares and Takeovers Regulations, 2011. This regulation applies to persons holding more than 25% voting rights in a company, who must annually disclose that they have not made further acquisitions beyond the creeping acquisition limit (typically 5% per financial year) without making an open offer. The filing appears to be a routine compliance submission and no specific details on shareholding percentage changes or pledge activity are mentioned in the headline.
This is a routine regulatory compliance filing and is unlikely to have any material impact on the stock price or shareholder value. It simply confirms adherence to takeover disclosure norms by a major shareholder.